FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to hematology, and can be used for morphometric assessment of prediction of diffuse B-large-cell lymphoma (DBLCL). That is ensured by determining STAT3+ tumor cell count in the lymph nodes. Lymphadenectomy in histological sections of the lymphoid organ is followed by immunohistochemical staining and the relative number of STAT3+ tumor cells in the lymph node in % is measured morphometrically. If the relative number of STAT3+ tumor cells is less than 66 %, a favorable course of diffuse B-large-cell lymphoma is stated. If the disease is equal or more than 66 %, an unfavorable course of the disease is stated.
EFFECT: invention allows predicting the flow DBLCL in patients after lymphadenectomy.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MORPHOMETRIC ASSESSMENT OF THE PREDICTION OF DIFFUSE B-LARGE-CELL LYMPHOMA BY CONTENT OF STAT3+ CELLS IN TUMOR TISSUE | 2019 |
|
RU2710591C1 |
| METHOD FOR MORPHOMETRIC ESTIMATION OF THE PROGNOSIS OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE INDEX OF THE PROPORTION OF TUMOUR CELLS EXPRESSING PSTAT3 AND PAKT1 IN LYMPH NODES | 2021 |
|
RU2767693C1 |
| METHOD OF MORPHOMETRIC PREDICTION OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BASED ON THE CONTENT OF AIF-POSITIVE TUMOR CELLS IN THE LYMPH NODES | 2023 |
|
RU2798958C1 |
| METHOD OF MORPHOMETRIC PREDICTION OF COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BASED ON CONTENT OF p16INK4A- AND p14ARF-POSITIVE TUMOUR CELLS IN LYMPH NODES | 2023 |
|
RU2814849C1 |
| METHOD FOR MORPHOMETRIC PREDICTION OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE CONTENT OF P14ARF-POSITIVE TUMOR CELLS IN THE LYMPH NODES | 2022 |
|
RU2785907C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF DIFFUSE LARGE B-CELL LYMPHOMAS | 2020 |
|
RU2750103C1 |
| METHOD FOR MORPHOMETRIC ESTIMATION OF PREDICTION OF CLINICAL COURSE OF NODULAR SCLEROSIS OF HODGKIN LYMPHOMA BY A PERCENTAGE SCORE CD163+ AND CD68+ MACROPHAGES IN LYMPH NODES | 2020 |
|
RU2738863C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RECURRENCE OF DIFFUSE LARGE B-CELL LYMPHOMA | 2021 |
|
RU2758126C1 |
| METHOD OF PREDICTING EFFICIENCY OF TREATMENT OF PATIENTS WITH HIGH GRADE NON-HODGKIN LYMPHOMA | 2013 |
|
RU2533816C2 |
| METHOD OF DIFFERENTIATED TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOSARCOMAS OF LYMPHOID ORGANS IN ADULTS | 2009 |
|
RU2421217C2 |
